BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9875316)

  • 1. Role of the transmembrane sequence of spleen focus-forming virus gp55 in erythroleukemogenesis.
    Fang C; Choi E; Nie L; Li JP
    Virology; 1998 Dec; 252(1):46-53. PubMed ID: 9875316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both the changes of six amino acids and the C-terminal truncation caused by a one-base insertion in the defective env gene of Friend spleen focus-forming virus significantly affect the pathogenic activity of the encoded leukemogenic membrane glycoprotein (gp55).
    Watanabe N; Yugawa T; Ikawa Y; Amanuma H
    J Virol; 1995 Dec; 69(12):7606-11. PubMed ID: 7494268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of the structure-function relationship of the leukemogenic membrane glycoprotein (GP55) of Friend spleen focus-forming virus (F-SFFV).
    Amanuma H; Yugawa T; Watanabe N; Ikawa Y
    Leukemia; 1997 Apr; 11 Suppl 3():160-1. PubMed ID: 9209329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor.
    Li JP; D'Andrea AD; Lodish HF; Baltimore D
    Nature; 1990 Feb; 343(6260):762-4. PubMed ID: 2154701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of the erythropoietin receptor and gp55.
    D'Andrea AD
    Cancer Surv; 1992; 15():19-36. PubMed ID: 1451111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence flexibility in the polytropic env gp70-derived region of the membrane glycoprotein (gp55) of Friend spleen focus-forming virus affects its biological activity.
    Yugawa T; Amanuma H
    J Virol; 1998 Mar; 72(3):2272-9. PubMed ID: 9499086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo and in vivo biological effects of a truncated form of the receptor tyrosine kinase stk when activated by interaction with the friend spleen focus-forming virus envelope glycoprotein or by point mutation.
    Rulli K; Yugawa T; Hanson C; Thompson D; Ruscetti S; Nishigaki K
    J Virol; 2004 May; 78(9):4573-81. PubMed ID: 15078939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirement of the single base insertion at the 3' end of the env-related gene of Friend spleen focus-forming virus for pathogenic activity and its effect on localization of the glycoprotein product (gp55).
    Amanuma H; Watanabe N; Nishi M; Ikawa Y
    J Virol; 1989 Nov; 63(11):4824-33. PubMed ID: 2552155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of gp55 in restoring the sensitivity of Friend murine erythroleukemia cells to erythropoietin by exposure to dimethyl sulfoxide.
    Lin TS; Ishiguro K; Sartorelli AC
    Oncol Res; 1998; 10(4):175-84. PubMed ID: 9778688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired activation and binding of the erythropoietin receptor by a mutant gp55 of Friend spleen focus-forming virus, which has a cytoplasmic domain.
    Yugawa T; Amanuma H
    Virology; 1998 Jul; 246(2):232-40. PubMed ID: 9657942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenicity of a mutant friend spleen focus-forming virus encoding an Env-like membrane glycoprotein (gp55) with substitution by a xenotropic murine leukemia virus Env gp70 sequence.
    Yugawa T; Amanuma H
    Microbiol Immunol; 1998; 42(4):335-9. PubMed ID: 9623923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Employment of a [3H]thymidine-incorporation assay to distinguish the effects of different Friend erythroleukemia-inducing retroviruses on erythroid cell proliferation.
    Ruscetti SK
    J Natl Cancer Inst; 1986 Jul; 77(1):241-5. PubMed ID: 3459916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell surface site for mitogenic interaction of erythropoietin receptors with the membrane glycoprotein encoded by Friend erythroleukemia virus.
    Ferro FE; Kozak SL; Hoatlin ME; Kabat D
    J Biol Chem; 1993 Mar; 268(8):5741-7. PubMed ID: 8449938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The envelope glycoprotein of friend spleen focus-forming virus covalently interacts with and constitutively activates a truncated form of the receptor tyrosine kinase Stk.
    Nishigaki K; Thompson D; Hanson C; Yugawa T; Ruscetti S
    J Virol; 2001 Sep; 75(17):7893-903. PubMed ID: 11483734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apparent Epo-independence of erythroid cells infected with the polycythemia-inducing strain of Friend spleen focus-forming virus is not due to Epo production or change in number or affinity of Epo receptors.
    Ruscetti SK; Ruscetti FW
    Leukemia; 1989 Oct; 3(10):703-7. PubMed ID: 2550708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell surface activation of the erythropoietin receptor by Friend spleen focus-forming virus gp55.
    Li JP; Hu HO; Niu QT; Fang C
    J Virol; 1995 Mar; 69(3):1714-19. PubMed ID: 7853508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Friend spleen focus-forming virus induces factor independence in an erythropoietin-dependent erythroleukemia cell line.
    Ruscetti SK; Janesch NJ; Chakraborti A; Sawyer ST; Hankins WD
    J Virol; 1990 Mar; 64(3):1057-62. PubMed ID: 2154592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin receptor binds to Friend virus gp55 through other membrane components.
    Kishi A; Chiba T; Sugiyama M; Machide M; Nagata Y; Amanuma H; Taira H; Katsumata T; Todokoro K
    Biochem Biophys Res Commun; 1993 May; 192(3):1131-8. PubMed ID: 8507186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selectable retrovirus vectors encoding Friend virus gp55 or erythropoietin induce polycythemia with different phenotypic expression and disease progression.
    Ahlers N; Hunt N; Just U; Laker C; Ostertag W; Nowock J
    J Virol; 1994 Nov; 68(11):7235-43. PubMed ID: 7933106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of N-terminal sequences of the tyrosine kinase sf-Stk in transformation of rodent fibroblasts by variants of Friend spleen focus-forming virus.
    Umehara D; Kawamura M; Odahara Y; Watanabe S; Hanson C; Ruscetti S; Nishigaki K
    Int J Cancer; 2012 Sep; 131(5):1083-94. PubMed ID: 22034044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.